1.
Transcriptional Profiling of RV144 Participants Reveals a Gene Expression Signature that Correlates with Immunogenicity
by Cameron, M
AIDS research and human retroviruses, 2013-11-01, Vol.29 (11), p.A-173-A-174

2.
HVTN-Tested Candidate HIV Vaccines Induce Early, Antigen-Specific Plasmablast- and Tfh-like Responses in Peripheral Blood
by Heit, A
AIDS research and human retroviruses, 2013-11-01, Vol.29 (11), p.A-143

3.
Enhanced HIV-Specific CD8+ T Cell Responses Following Polytopic Administration of VRC rAd5 gag-pol/env A/B/C in HIV-Uninfected Healthy Adults
by Frank, I
AIDS research and human retroviruses, 2013-11-01, Vol.29 (11), p.A-63

4.
Immunogenicity of Homologous and Heterologous Regimens of Ad26-Enva.01 and Ad35-Enva HIV Vaccines in HIVUninfected Volunteers in the U.S. and Africa
by J Gilmour, J
AIDS research and human retroviruses, 2013-11-01, Vol.29 (11), p.A-69

5.
A Recombinant Vesicular Stomatitis Virus (rVSV) HIV-1 Gag Vaccine Is Safe and Immunogenic in Healthy, HIV-1 Uninfected Phase I Trial Participants
by Fuchs
AIDS research and human retroviruses, 2013-11-01, Vol.29 (11), p.A-74-A-75

6.
HVTN 505: Efficacy of a Multi-Gene DNA Prime/Recombinant Adeno 5 (rAd5) Vector Boost Vaccine in Men & Transgender Women (TGW) Who Have Sex with Men
by Hammer, S
AIDS research and human retroviruses, 2013-11-01, Vol.29 (11), p.np-np

7.
Association of FccRIIC Polymorphism with Vaccine Efficacy and Correlates of HIV-1 Infection Risk in RV144
by Li, S S
AIDS research and human retroviruses, 2013-11-01, Vol.29 (11), p.A-178-A-179

8.
Differences in the expressed HLA class I alleles effect the differential clustering of HIV type 1-specific T cell responses in Infected Chinese and Caucasians
by YU, Xu G
AIDS research and human retroviruses, 2004, Vol.20 (5), p.557-564
